Biotech Week articles from February 2003

Biotech Week archives from February 2003

Promising cancer-fighting candidates emerge from tropical ocean "mud".
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Although the oceans cover 70% of the planet's surface, much of their biomedical potential has gone largely unexplored. Until now. A group of researchers at Scripps Institution of Oceanography at...

Researchers develop "smart" dressing.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Cotton gauze has been used to dress wounds for hundreds of years because it is naturally soft, pliable, and absorbent. Now, a scientist from the Agricultural Research Service and his collaborators are...

Sugars research affecting bypass patients, drug industry.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- A young Massachusetts Institute of Technology (MIT) professor's basic research on complex sugars has led to a cascade of potential medical applications that could, for example, significantly improve...

New agents display selectivity for estrogen receptor beta.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Researchers at a major drug firm have reported on a new line of estrogen receptor modulators with selectivity for estrogen receptor beta. The scientists described "a series of 1,3,5-triazine-based...

Enhancing alpha-helicity HIV peptide increases affinity for human monoclonal antibody 2F5.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- "The synthetic peptide DP178, derived from the carboxyl-terminal heptad repeat region of human immunodeficiency virus type 1 GP41 protein is a potent inhibitor of viral-mediated fusion and contains the...

Clozaril receives first indication to reduce risk of suicide.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- The antipsychotic drug Clozaril has received the U.S. Food and Drug Administration's (FDA) first indication for reducing the risk of recurrent suicidal behavior in people with schizophrenia or...

Donor immunization may lower pneumococcal infection risk.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Immunization of hematopoietic stem cell donors may help prevent pneumococcal infections in transplant recipients, according to researchers in the United States....

Former WebMD executive producer joins NewsRx.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- A former WebMD executive producer and medical editor has joined Atlanta-based NewsRx, along with three board-certified editors. Dominique Walton Brooks, MD, with WebMD until 2001, will serve as...

Growing human antibodies in algae inexpensive route to large-scale production.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- A group of scientists at the Scripps Research Institute (TSRI) have used algae to express an antibody that targets herpes virus. This antibody could potentially be an ingredient in an antiherpes...

Positive clinical data from melanoma cancer vaccine trial announced.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology (GZMO) announced positive findings from the completion of one of its cancer vaccine studies in melanoma. The phase I/II trial is the first one of its kind to have used two...

Product partnership signed for novel cancer drug in China.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- AEterna Laboratories, Inc., (AEL; AELA) announced that its biopharmaceutical subsidiary Zentaris AG and Hainan Tianwang International Pharmaceutical signed a contract for the manufacture and marketing...

Drug access program set up for Humira for Medicare-eligible seniors.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced the launch of the Humira Medicare Assistance Program, an unprecedented drug access program that will provide its newly approved rheumatoid arthritis (RA) drug, Humira...

SpectRx seeks to terminate glucose monitoring development agreement.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- SpectRx, Inc., (SPRX) announced that it has delivered a notice to Abbott Laboratories (ABT) that SpectRx is taking actions required to terminate its research, development, and license agreement with...

Morphotek enters agreement to develop high-titer antibody cell lines.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Morphotek, Inc., announced that it has signed a research agreement with Abgenix, Inc., of Fremont, California, for use of its proprietary Morphodoma technology in the development of high-titer cell...

Phase II study of amikacin will soon start in patients on mechanical ventilators.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Speaking at the JPMorgan H&Q Health Care Conference in San Francisco, Aerogen, Inc., (AEGN) announced that it has completed plans for and will soon initiate a phase II clinical trial in France to...

Team uses genomic tools to discover gene for childhood genetic disorder.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- In an advance illustrating the power of genomic information, an international team of researchers has identified a gene that causes Leigh syndrome, French Canadian type (LSFC), a fatal inherited...

Phase II cancer compound licensed.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that it has signed a multi-institutional licensing agreement for a phase II cancer compound, thus further expanding its oncology development pipeline. ...

FDA grants approval for Aralast.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Alpha Therapeutic Corporation (Alpha) and Baxter Healthcare Corporation (Baxter) announced that Alpha has received U.S. Food and Drug Administration (FDA) authorization for Aralast alpha-1 proteinase...

Diluted earnings per share outlook are expected to be $1.15-$1.25.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO) announced its financial expectations for 2003. The company expects 2003 revenues to grow 8-10% to $1.325-$1.350 billion, with operating margins improving slightly. Diluted...

TriPath Oncology inks agreement to commercialize melanoma gene assay.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- TriPath Oncology, Inc., a wholly owned subsidiary of TriPath Imaging, Inc., (TPTH) announced that it has signed a definitive agreement with AmeriPath, Inc., (PATH) to commercialize a novel gene...

German study finds possible cause of high blood pressure.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- The American Kidney Fund (AKF) is encouraged by a German study that indicates that some people may be born at risk for high blood pressure because they have fewer filters in their kidneys than normal....

Many states fail to protect public against second-hand smoke.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Four years after securing more than $240 billion in tobacco settlements, most U.S. states have squandered the unprecedented opportunity to fund comprehensive tobacco initiatives proven to help protect...

FDA approval granted for 180 days of marketing exclusivity.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, APP, (APPX) announced that it has received 180 days of marketing exclusivity and approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated New Drug...

Federal Appeals Court affirms infringement.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) announced that the U.S. Court of Appeals for the Federal Circuit upheld the District Court's decision that TKT and Aventis infringe two of Amgen's patents relating to erythropoietin. ...

Senior medical informaticist added to staff.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Adding to its team of informatics, medical, and life sciences experts, AnVil, Inc., a pioneer in life sciences discovery, announced the hire of Steven A. Henry, MD, MS, as senior medical informaticist....

Mera Pharmaceuticals to acquire botanical drug development company.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Mera Pharmaceuticals, Inc., (MRPI) announced that it has entered into a binding commitment to acquire Ancile Pharmaceuticals, Inc., a privately held drug development company with a focus on botanical...

Biologic response modifiers show progress against RA.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- The Arthritis Foundation reports an important development involving a class of biologic response modifiers called tumor necrosis factor (TNF) inhibitors used in the treatment of rheumatoid arthritis...

FDA requires more time for review of Iressa.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has notified AstraZeneca (AZN) that it requires more time to review information requested of the company during the 6-month priority review of the new drug...

Pain cream taken off the market.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- EMLA Cream, an anesthetic cream produced by AstraZeneca, has been temporarily taken off the market in the United States because the packaging does not comply with the Poison Prevention Packaging Act....

$13.7M equity financing closed.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Aton Pharma, Inc., announced that it has closed an equity financing of $13.7 million. Participants in the financing included new investors Perseus-Soros Biopharmaceutical Fund and The Wellcome...

Japanese Eligard marketing rights licensed to Sosei.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) and Sosei Co., Ltd, announced that Atrix and Sosei have executed an exclusive agreement for the license to develop and commercialize Eligard in Japan. Eligard...

FDA panel recommends approval of Ketek for respiratory tract infections.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Aventis announced that the Anti-Infective Drugs Advisory Committee (AIDAC) of the U.S. Food and Drug Administration (FDA) voted to recommend approval of Ketek (telithromycin) tablets (800 mg oral dose...

New systems make diabetes monitoring easier, less painful.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Becton, Dickinson and Company (BD) (BDX) has announced the U.S. availability of two new U.S. Food and Drug Administration (FDA)-cleared blood glucose monitoring products designed to help improve...

New glucosamine fermentation process to be commercialized.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Bio-Technical Resources (BTR), a division of Arkion Life Sciences LLC, announced it is commercializing its technology to produce glucosamine by microbial fermentation, with product availability in the...

Licensing agreement with PPD to use nano-delivery technology.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- BioDelivery Sciences International, Inc., (BDSI)(BDSIW) announced it has signed a license agreement with PPD, Inc. Under the terms of the agreement, BDSI granted PPD the right to apply BDSI's...

Survey looks at perceptions of brand in the life-science market.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Like most consumers, scientists want the products they buy for their labs to perform consistently, deliver reliable results, and offer the best possible value for money. And, like most consumers,...

Companies to develop hormone therapy product under license agreement.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has signed a development and license agreement with Teva Pharmaceuticals USA, Inc., a wholly owned subsidiary of Teva Pharmaceutical Industries,...

Brookhaven Lab's synthetic growth factor technology licensed.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- BioSurface Engineering Technologies, Inc., (BioSET), of College Park, Maryland, has obtained an exclusive worldwide license to a novel growth factor technology developed by scientists at the U.S....

CEO profiles long-term earnings growth potential of 20%.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) chairman and CEO James Mullen outlined the company's strategy to reach an average earnings growth rate of 20% over the next 3 years. Mullen's remarks were presented at the J.P....

Sunesis enters collaboration for inflammatory and immunological diseases.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Sunesis Pharmaceuticals, Inc., announced that the company has entered into a collaboration with Biogen, Inc., (BGEN) to discover oral therapeutics for the treatment of inflammatory and autoimmune...

Vice president of medical affairs named.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Biopure Corporation (BPUR) announced that Douglas M. Hansell, MD, MPH, has joined the company as vice president of Medical Affairs. An anesthesiologist from Massachusetts General Hospital, Hansell...

FDA approves 20 new biotech products, 15 new indications.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) approved 35 new biotechnology-based drugs and vaccines as well as new indications for previously approved products in 2002, up slightly from 2001, according...

$5M raised in venture financing.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Biotica Technology Limited announced the completion of a $5 million Series A round of financing, led by Biotechnology Value Fund (San Francisco, CA) with co-investor Nordic Biotech (Copenhagen). ...

Carignan named medical director, vice president of clinical affairs.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced the appointment of Charles Carignan, MD, to the newly created position of medical director and vice president of Clinical Affairs for the company's...

Antitrust litigation to be settled.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) announced that it has reached agreements, in principle, that would settle substantially all antitrust litigation surrounding two of its products, the anti-anxiety drug...

Some cancers show more hereditary linkage than others in Swedish study.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- According to recent research from Sweden, "familial risks for histopathology-specific cancers have not been determined. We used the nationwide Swedish Family-Cancer Database on 10.2 million individuals...

New nonexecutive director named.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology (CATG) has announced the appointment of Peter Ringrose as a nonexecutive director to the board, effective February 10, 2003. Peter Ringrose has spent his 32-year career...

Presence of certain tumor markers could signal best results for vaccine.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Scientists at the John Wayne Cancer Institute (JWCI) in Santa Monica, California, have found a panel of molecular markers that could signal which patients might have the best results following...

Financial results announced, $1.35M in new funding reported.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corporation (CVM) reports financial results for the 2002 fiscal year ending September 30, 2002. During fiscal year 2002, grant revenues were $384,939 as compared with $293,871 during fiscal...

Revimid monotherapy induces reduction or stabilization of paraprotein levels.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Celgene Corp. (CELG) announced that Paul Richardson, MD, of the Dana-Farber Cancer Institute at Harvard University, presented preliminary results from a randomized phase II trial of Revimid (CC-5013) in...

Update provided on clinical pipeline.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) announced during the company's presentation at the JP Morgan H&Q Healthcare Conference that it had advanced several of its clinical programs. "We are moving forward with...

Record 4Q revenues, backorders predicted for 2003.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Cell Robotics International, Inc., (CRII) announced estimated record revenues for the fourth quarter and record backorders exceeding total 2002 revenues. The company expects to report product sales...

Three new software modules launched for ArrayScan HCS Reader.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Cellomics, Inc., announced the release of three new BioApplication software modules, Molecular Translocation, Micronucleus, and Cell Cycle, for the ArrayScan High Content Screening (HCS) Reader and the...

Dipentum relaunched in U.S.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Celltech Pharmaceuticals has announced the relaunch of Dipentum (olsalazine sodium capsules) in the U.S. market. Dipentum is indicated for the maintenance of remission of ulcerative colitis (UC) in...

New company to develop pharmaceuticals for diseases of aging.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Centagenetix, Inc., and Elixir Pharmaceuticals, Inc., announced that the two companies will merge to create pharmaceutical products that address the diseases of aging. The all-stock transaction is...

Research deal to enhance drug discovery efforts.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Cephalon, Inc., (CEPH) and MDS Proteomics, Inc., a subsidiary of MDS, Inc., (MDZ; MDS), announced that the companies have entered a 5-year agreement that will use MDS Proteomics' technologies to further...

Partnership to target development of obesity drug program.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) announced that it has entered an exclusive partnership with GlaxoSmithKline (GSK) for the research, development, and commercialization of Chiron's small molecule drug program...

Hein named president, CEO.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Chromatin, Inc., announced that its board of directors has appointed Mich Hein as president and CEO effective January 1, 2003. Prior to assuming his position with Chromatin, Hein founded Epicyte...

New drug application for Pegasys filed in Japan.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, announced that it has filed a new drug application (NDA) for Pegasys monotherapy (peginterferon alfa-2a), to treat chronic hepatitis C in...

Pharmacogenomics agreement signed; clinical update provided.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- CuraGen Corporation (CRGN), a genomics-based pharmaceutical company, announced that CuraGen and Pfizer, Inc., (PFE) scientists are working together to evaluate compounds under consideration at Pfizer....

Company moves to OTC Bulletin Board.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Cygnus, Inc., (CYGN) announced that its common stock will be moved to the OTC Bulletin Board effective at the open of business on January 8, 2002. This is a result of the company's ineligibility to...

Genotyping business acquired.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- DNA LandMarks, Inc., and Paradigm Genetics, Inc., (PDGM) announced they have entered into a letter of intent comprising DNA Landmark's acquisition of ParaGen, the plant genotyping business of Paradigm...

Rigel receives milestone payment in cancer drug deal.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) announced that it has received the first milestone payment from Daiichi Pharmaceuticals Co., Ltd., in conjunction with the companies' partnership to develop a new...

New DeltaOne customers announced.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Deltagen, Inc., (DGEN) announced that the company has added to new customers to its DeltaOne program. The new customers are Aventis Pharmaceuticals, Inc., (AVE) and Euroscreen. DeltaOne is one of...

Grant awarded for ion channel research.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Devgen, a privately held functional genomics and drug discovery company, announced that it has been awarded a EUR 2.5 million technology development grant from the Flemish government to support its...

Novogen receives $1.3 million royalty payment for soy isoflavone technology.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Novogen, Ltd., (NVGN) announced receipt of a milestone royalty payment of $1.3 million under a license agreement signed with DuPont Protein Technologies. The companies entered into this license...

Landmark asthma patent granted.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Dynavax Technologies, a privately held biopharmaceutical company, and the Regents of the University of California announced that the university has been granted U.S. Patent No. 6,498,148 B1 (the '148...

Second deal signed to study pharmacogenetics of depression treatment.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- EGeen International and Prediction Sciences announced the signing of an agreement to collaborate on the study and discovery of genetic variants responsible for variable patient response to paroxetine...

Progress in advancements of cardiovascular disease therapies announced.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Edwards Lifesciences Corporation (EW) announced that it has acquired CardioFocus, Inc.'s surgical business for treating cardiac arrhythmias, and also has completed a key milestone in pursuit of U.S....

Major expansion initiated to increase pharmaceutical sales by 60%.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Eisai, Inc., a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., announced plans to strengthen its national sales force by adding an additional 150 sales representatives. The expansion...

Exercisability of premerger Endo warrants announced.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Endo Pharmaceuticals Holdings, Inc., (ENDP; ENDPW) announced that the outstanding warrants that were issued to Endo Pharma LLC (an affiliate of Kelso & Company in which certain members of management...

Patent application filed for ENT-103.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Entropin, Inc., (ETOP) announced the filing of a composition-of-matter patent for ENT-103, a new chemical entity and a simplified next generation form of the company's previous key investigational...

FDA clears initiation of lung, colorectal cancer vaccine trials.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has received clearance from the U.S. Food and Drug Administration to start phase I/II clinical trials of its EP-2101 therapeutic, multi-epitope vaccine in lung...

Drug discovery alliance announced.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Evotec OAI AG (EVT) and Oxagen Limited announced that they have entered into an alliance to identify chemical compounds interacting with one of Oxagen's lead drug targets. In the search for new...

Company reiterates guidance.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Fisher Scientific International, Inc., (FSH) reiterated its guidance for 2002 and 2003. For 2002, Fisher expects revenue growth, excluding foreign-exchange effects, of approximately 12%, and...

Report: Pharmacogenomics market expected to nearly triple by 2008.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Front Line Strategic Consulting, Inc., a management consulting and market research company for the life-sciences industries, announced a new strategic market report, "Pharmacogenomics: A Strategic...

$4.5M debenture round completed.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- GB Therapeutics, Ltd. announced the completion of a $4.5 million debenture round led by VenGrowth Capital Partners and University Medical Discovery Investments. The debenture will convert as part of...

Two milestones achieved in drug alliance.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Martinsried/Munich, Germany, and U.S. Research Facilities in GPC Biotech AG (GPC) announced that it has achieved two milestones by using its Reverse Genomics technology platform for the analysis of the...

Candidate for PAD didn't meet clinical expectations; vaccine update provided.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC), a biopharmaceutical company developing gene-based medicines, announced top line findings from a phase II study with its product candidate for the treatment of poor blood flow in...

HAP technology license agreement signed with Millennium.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Genaissance Pharmaceuticals, Inc., (GNSC) announced that it has licensed its HAP Technology to Millennium Pharmaceuticals, Inc., (MLNM) for use in its drug discovery and development programs. Under...

Confirmatory phase III trial for Prestara initiated.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Genelabs Technologies, Inc., (GNLB) announced that it has initiated its confirmatory phase III clinical trial for Prestara (prasterone), the company's investigational drug for systemic lupus...

Protein Polymer Technologies receives milestone payment.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Protein Polymer Technologies, Inc., (PPTI) announced the receipt of its first milestone payment from Genencor International, Inc., under the worldwide exclusive license agreement established at the end...

First milestone achieved in antibody alliance.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced that it has achieved the first milestone in its collaboration with Roche, as a human antibody generated by Genmab has effectively reached proof of concept in an animal disease...

SBIR grant to be used for development of drug toxicity predictor.
February 5, 2003... 2003 FEB 5 - (NewsRx.com & NewsRx.net) -- Genomatica, Inc. announced it has received a Small Business Innovative Research (SBIR) Grant from the U.S. Department of Defense, Defense Advanced Research Projects Agency (DARPA) to develop in silico...